The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis
Public ClinicalTrials.gov record NCT05772520. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blinded, Placebo-controlled, Multicenter Phase 2 Study Evaluating the Efficacy and Safety of TLL018 in Participants With Moderate-to-severe Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2, multicenter, randomized, double-blinded, parallel dose group, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of 2 doses of TLL018 as therapy in approximately 90 participants with moderate-to-severe PP.
Study identification
- NCT ID
- NCT05772520
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 82 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 19, 2023 (Actual)
- Primary completion
- Dec 1, 2024 (Actual)
- Completion
- Dec 23, 2024 (Actual)
- Last update posted
- Jul 21, 2026
2023 – 2024
United States locations
- U.S. sites
- 35
- U.S. states
- 15
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cahaba | Birmingham | Alabama | 35244 | — |
| Moy, Fincher, Chipps | Beverly Hills | California | 90210 | — |
| Metropolis Derm | Los Angeles | California | 90017 | — |
| Amicis Research Center | Northridge | California | 91324 | — |
| Integrative Skin | Sacramento | California | 95815 | — |
| Skin Surgical | San Diego | California | 92117 | — |
| Life Clinical Trials | Coral Springs | Florida | 33071 | — |
| Palm Beach | DeLand | Florida | 33484 | — |
| D&H Doral Research Center LLC | Doral | Florida | 33122 | — |
| Sweet Hope Research Specialty, Inc | Hialeah | Florida | 33016 | — |
| CNS - Jacksonville | Jacksonville | Florida | 32256 | — |
| CNS - Orlando SODO | Jacksonville | Florida | 32256 | — |
| Altus Research | Lake Worth | Florida | 33461 | — |
| Anchor Medical Research, LLC (Core Clinical Trials) | Miami | Florida | 33176 | — |
| Reserka Research | Miami | Florida | 33176 | — |
| ForCare Medical (CenExcel) | Tampa | Florida | 33613 | — |
| Integrated Clinical Trial Services, Inc | Des Moines | Iowa | 50265 | — |
| IMA Clinical Research | Monroe | Louisiana | 71201 | — |
| Lawrence Green | Rockville | Maryland | 20850 | — |
| Metro Boston | Brighton | Massachusetts | 02135 | — |
| Oakland Hills Dermatology | Auburn Hills | Michigan | 48326 | — |
| Revival Research Institute | Troy | Michigan | 48084 | — |
| Grekin Skin | Warren | Michigan | 48088 | — |
| Minnesota Clinical Study Center | New Ulm | Minnesota | 55112 | — |
| Mount Sinai | New York | New York | 10003 | — |
| Sadick Research Group | New York | New York | 10075 | — |
| Remington-Davis, Inc. | Columbus | Ohio | 43215 | — |
| DermDox | Sugarloaf | Pennsylvania | 18249 | — |
| CRCC | Charleston | South Carolina | 29407 | — |
| Dermatology Associates of Knoxville | Knoxville | Tennessee | 37909 | — |
| Derm Research | Austin | Texas | 78759 | — |
| Studies in Dermatology, LLC | Cypress | Texas | 77433 | — |
| Austin Institute for Clinical Research | Pflugerville | Texas | 78660 | — |
| Progressive Clinical Research Group, Inc. | San Antonio | Texas | 78213 | — |
| Acclaim | Sugar Land | Texas | 77479 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05772520, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 21, 2026 · Synced Oct 31, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05772520 live on ClinicalTrials.gov.